Shandong Suncadia Medicine Co., Ltd.

This study is testing an investigational drug called HRS-1780 to see if it can safely lower blood pressure in adults with primary aldosteronism, a condition where the adrenal glands produce too much of a hormone that raises blood pressure. About 60 participants will be randomly a…

This study is testing a new drug called HRS-1893 for people with a specific type of heart failure where the heart pumps normally but doesn't relax properly. The main goal is to see if the drug is safe and well-tolerated. Researchers will also check if it helps improve symptoms, w…

This early-stage clinical trial is testing several combinations of experimental drugs (HRS-6208, HRS-8080, HRS-6209) with existing breast cancer medications (fulvestrant, letrozole) for people with advanced, spreading breast cancer that cannot be surgically removed. The main goal…

This study aims to see if a new drug called HRS-2129 can safely reduce pain from diabetic nerve damage. It will compare the drug against a placebo (a dummy pill) and an existing pain medication (pregabalin) in 168 Chinese adults with this condition. The main goal is to measure ch…

This is an early safety study to see how a new cholesterol-lowering drug (HRS-1301) is processed by the body in people with mild, moderate, or severe kidney problems. Researchers will compare the drug's levels in the blood and urine of 36 participants with kidney issues to those …

This early-stage study aims to understand how a potential new breast cancer drug, called HRS-8080, is absorbed, broken down, and removed from the body. Researchers will give a tiny, safe amount of a radioactive version of the drug to six healthy postmenopausal women to track its …

This early-stage study aims to see if two different versions of an experimental tablet called HRS-1893, intended for a heart muscle condition, work the same way in the body. It will involve 36 healthy adults to compare how the drug is absorbed and processed, and to check for safe…